Udary mózgu u starszych kobiet - czynniki ryzyka i rokowanie

• Authors: Anna Członkowska , Adam Kobayashi

Title variants

EN

Stroke in elderly women - risk factors and prognosis

• Languages of publication: PL EN

Abstracts

EN

Summary Stroke morbidity increases with age. That is the reason why it affects especially the middle aged and elderly. Because of longer life expectancy, by ca. 10 years, stroke is a major problem in women. 8% of males and 16% of females die due to stroke. Risk factors are basically the same in both sexes. The most important are hypertension, diabetes, dyslipidaemia, atrial fibrillation, coronary heart disease, previous stroke, smoking, alcohol abuse, obesity and lack of physical activity. Their impact, however, is different in males and females. Women with diabetes, atrial fibrillation, myocardial infarction, obese, drinking excessive amounts of alcohol and smoking are more likely to suffer of stroke than males with the same burden. Up to the age of 55, the course of stroke in women is less severe and the outcome more favorable. Women older than 55 have more severe strokes and higher stroke fatality and disability than men of the same age. It is possible that poor prognosis is related to a drop in blood estrogen concentration after menopause.

• Journal: Kosmos
• Year: 2003
• Volume: 52
• Issue: 1
• Pages: 77-82

Dates

published

2003

Contributors

author

Anna Członkowska

• II Klinika Neurologiczna, Instytut Psychiatrii i Neurologii, Sobieskiego 1/9, 02-957 Warszawa, Polska

author

Adam Kobayashi

• II Klinika Neurologiczna, Instytut Psychiatrii i Neurologii, Sobieskiego 1/9, 02-957 Warszawa, Polska

References

• ALBERS G. W., HART R. G., LUTSEP H. L., NEWELL D. W., SACCO R. L., 1999. A statement of the Ad hoc Committee on the guidelines for the management of transient ischemic attack. Stroke 30, 2502-2511.
• AMERICAN HEART ASSOCIATION, 1997. Heart and stroke facts: statistical update. American Heart Association. Dallas, Tex.
• BARNET H. J. M., TAYLOR W., ELIASZIW M., FOX A. J., FERGUSON G.G., HAYNES R. B., RANKIN R. N., CLAGET G. P., HACHINSKI V. C., SACKETT D. L., THORPE K. E., MELDRUM H. E., 1998. Benefit of carotid endarterectomy in patients with symptomatic moderate and sever stenosis. New Engl. J. Med. 339, 1415-1425.
• BONITA R., 1992. Epidemiology of stroke. Lancet 339, 342-344.
• BORSTEIN N. M., 2001. Acetylsalicic acid (Aspirin). [W:] Stroke prevention. NORRIS J.W., HACHINSKI V. (red.). Oxford, New York, 177-94.
• BOUSSER M-G., 1999. Stroke in women. Circulation.99, 463-467.
• BOUSSER M-G., KITTNER S. J., 2000. Oral contraceptives and stroke. Cephalalgia 20, 183-189.
• EASTON J. D., 2001. Antiplatelet therapy. [W:] Stroke prevention. NORRIS J. W., HACHINSKI V. (red.). Oxford, New York, 195-210.
• FOTHERBY M.D., PANAYIOTOU B., 1999. Antihypertensive therapy in prevention of stroke. Drugs 58, 663-674.
• GORELICK P. B., 1997 Stroke prevention: Windows of opportunity and failed expectations? - A discussion of modifiable cardiovascular risk factors and a prevention proposal. Neuroepidemiology 16, 163-173.
• GORELICK P. B., SACCO R. L., SMITH D. B., ALBERTS M., MUSTONE-ALEXANDER L., RADER D., ROSS J. L., RAPS E., OZER M. N., BRASS L. M., MALONE M. E., GOLDBERG S, BOOSS J., HANLEY D. F., TOOLE J. F., GREEWOLD N. L., RHEW D. C., 1999. Prevention of first stroke. A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 281, 1112-1120.
• HEART PROTECTION STUDY COLLABORATIVE GROUP, 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial.
• Lancet 360, 7-22.
• HOLROYD-LEDUC J. M., KAPRAL M. K., AUSTIN P. C., TU J. V., 2000. Sex differences and similarities in the management and outcome of stroke patients. Stroke 31, 1833-1837.
• HURN P. D.,MACRAE I. M., 2000. Estrogen as a neuroprotective in stroke. J. Cereb. Blood Flow Metab. 20, 631-652.
• INTERNATIONAL STROKE TRIAL COLLABORATIVE GROUP, 1997. International stroke trial (IST). Lancet 349, 1569-1581.
• LEVEILLE S. G., RESNICK H. E., BALFOUR J., 2000. Gender differences in disability: evidence and underlaying reasons. Aging Clin. Exp. Res. 12, 106-112.
• PAERSON T. A., BLAIR S. N., DANIELS S. R., ECKEL R. H., FAIR J. M., FORTMANN S. P., FRANKLIN B. A.,GOLDSTEIN L. B., GREENLAND P., GRUNDY S. M., HONG Y. L., MILLER N. H., LAUER R. M., OCKENE I. S., SACCO R. L., SALLIS J. F., SMITH S. C., STONE N. J., TAUBERT K. A., 2002. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Circulation 106, 388-391.
• ROSENDORFF C., 1998. Statins for prevention of stroke. Lancet 351, 1002.
• SACCO R. L., BENJAMIN E. J., BRODERICK J. P., DYKEN M., EASTON J. D,, FEINBERG W. M., GOLDSTEIN L. B., GORELICK P. B.,HOWARD G.,KITTNER S. J.,MANOLIO T. A., WHISNANT J. P., WOLF P. A., 1997. Risk factors. Stroke 28, 1507-1517.
• SANDERCOCK P., TANGKANAKUL C., 1997. Very early of stroke recurrence. Cerebrovasc. Dis. Suppl. 1, 10-15.
• SIMON J. A., HSIA J., CAULEY J. A., RICHARDS C., HARRIS F., FONG J., BARRETT-CONNOR E., HULLEY S.B., 2001. Postmenopausal hormone therapy and risk of stroke. The heart and estrogen-progestin replacement study (HERS). Circulation 103, 638-642.
• STAESSEN J.,WANG J., 2001. Blood-pressure lowering for secondary prevention of stroke. Lancet 358, 1026-1028.
• STEIN D. G., 2001. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? TINS 24, 386-391.
• THOMSON R., PARKIN D., ECCLES M., SUDLOW M., ROBINSON A., 2000. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 355, 956-962.
• WRITING GROUP FOR THE WOMEN´S HEALTH INTIATIVE INVESTIGATORS., 2002. Risk and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288, 321-333.
• YAMAMOTO H., BOGOUSSLAVSKY J., 1998. Mechanism of second and further strokes. J. Neurol. Neurosurg. Psychiat. 64, 771-776.